Pittsburgh-based UPMC recorded an operating income of $286 million (0.9% operating margin) in 2025, an improvement from an operating loss of $339 million (-1.1% margin) in 2024, according to its Feb. 27 financial report.
Five things to know:
1. UPMC said its $625 million operating improvement in 2025 was primarily driven by improved underwriting margin in its insurance division, along with enterprise-wide initiatives to reduce operational expenses through efficiency measures.
2. The system reported total operating revenue of $33.6 billion for the 12 months ended Dec. 31, up from $29.9 billion during the same period in 2024. Net patient service revenue was $13 billion, up from $12.2 billion. Insurance enrollment revenue was $17.6 billion, up from $15.1 billion.
3. Total operating expenses were $33.2 billion in 2025, up from $30.1 billion in 2024. Salaries, professional fees and benefits were $10.4 billion, up from $10 billion. Insurance claims expenses were $13.1 billion, up from $11.2 billion. Supplies, purchased services and general expenses were $9.1 billion, up from $8.2 billion.
4. UPMC reported $30 million in restructuring costs in 2025, compared to $128 million in 2024.
5. After accounting for nonoperating items, such as investment returns, UPMC reported a net income of $635.4 million in 2025, up from a net loss of $14.7 million in 2024.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
